摘要
肺动脉高压是一种罕见、进行性、致命的疾病,其昂贵的医疗费用给社会、家庭和个人带来沉重的经济负担。该文就国内外关于肺动脉高压的疾病经济负担现状进行回顾,旨在为合理分配卫生资源和有效制定卫生医疗政策提供参考。
Pulmonary arterial hypertension is a rare,progressive and fatal disease,its high medical costs bring about heavy financial burden on society,families and individuals.This article reviews the current status of the disease economic burden of pulmonary arterial hypertension at home and abroad,aiming to provide a reference for the rational allocation of health resources and the effective formulation of health care policies.
作者
何娟
方琴
HE Juan;FANG Qin(Department of Cardiovascular Medicine,First Affiliated Hospital of Chongqing Medical University,Chongqing 400016,China)
出处
《重庆医学》
CAS
2024年第15期2366-2369,共4页
Chongqing Medical Journal
基金
国家自然科学基金面上项目(82270061)
重庆医科大学附属第一医院护理科研基金项目(HLJJ2018-10)。
关键词
肺动脉高压
疾病经济负担
研究现状
费用
综述
pulmonary hypertension
economic burden of disease
research status quo
costs
review